×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Module 3: Phase 1
Session Chair(s)
Courtland R. LaVallee, MBA
Executive Director, Project Management
Dynavax Technologies, United States
- Sub-chronic Animal Toxicology
- Maximally Tolerated Dose (SD/MD)
- Preliminary Dose Form
- Dose Proportionality
- Intersubject PK Variation